+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
ID04939805

Study of Selective C-Reactive Protein Apheresis Using the PentraSorb System in Patients With ST-Elevation Myocardial Infarction Treated With Primary PCI

Led by Medical University Innsbruck · Updated on 2026-10-07

202

Participants Needed

5

Research Sites

45 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients who have had an acute ST-elevation myocardial infarction STEMI, a type of heart attack. The study evaluates a new treatment called selective C-reactive protein CRP apheresis, which is being assessed alongside standard care to see if it can reduce the size of the heart damage caused by the heart attack. This clinical trial is a randomized, controlled study aiming to provide evidence on the effectiveness of this treatment. Participants will receive selective CRP apheresis using the PentraSorb-CRP system on the first three days after undergoing primary percutaneous coronary intervention PCI, a procedure to open blocked heart arteries. The study compares this treatment plus standard care to standard care alone. The trial uses a two-group design and is conducted at multiple centers. During the study, participants will be closely monitored with various assessments, including cardiac magnetic resonance imaging CMR at baseline, 4 months, and 12 months after PCI. Researchers will measure heart function, infarct size, inflammation markers, and heart rhythm features. Safety is tracked during hospitalization, and follow-up continues for up to 12 months to record events like heart failure or mortality. The total participation lasts at least one year after treatment.

CONDITIONS

Brief Title

CRP Apheresis in STEMI

Research Team

S

Sebastian J Reinstadler, MD, PhD

I

Ivan Lechner, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here